Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-050907
Filing Date
2023-02-27
Accepted
2023-02-27 16:58:57
Documents
5
Effectiveness Date
2023-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d390124ds8.htm S-8 42939
2 EX-5.1 d390124dex51.htm EX-5.1 6893
3 EX-23.1 d390124dex231.htm EX-23.1 1474
4 EX-FILING FEES d390124dexfilingfees.htm EX-FILING FEES 17886
5 GRAPHIC g390124g83h10.jpg GRAPHIC 2793
  Complete submission text file 0001193125-23-050907.txt   74271
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270064 | Film No.: 23676212
SIC: 2836 Biological Products, (No Diagnostic Substances)